Larger prospective studies are essential to clarify whether the ADIPOQ gene rs266729 and CDKN2A/2B gene rs10811661 genotypes are associated with perinatal adverse outcomes in GDM patients. This evidence concerns the gene ADIPOQ and gestational diabetes.